OrthoPediatrics announced it has released the new Pediatric Nailing Platform TIBIA system and successfully completed the first cases in its limited launch. The Company received 510 clearance from the U.S. Food and Drug Administration for the system in September 2023. Part of the Trauma & Deformity Correction suite of products, PNP Tibia represents another pediatric-focused solution for treating patients with fractures and deformities in the lower extremities. It expands the Company’s offering to 52 unique systems designed specifically to help treat the needs of pediatric patients. Joe Hauser, President of OrthoPediatrics’ Trauma & Deformity Correction business stated, “It is extremely gratifying to see the system perform successfully in two unique and challenging cases. It shows the expert surgeon design team hit the mark along with OP engineers to design a system that will help many kids in the years to come”.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on KIDS:
- OrthoPediatrics Corp. Launches Pediatric Nailing Platform | Tibia
- OrthoPediatrics Corp. to Report Third Quarter 2023 Financial Results on November 7, 2023
- OrthoPediatrics price target lowered to $31 from $51 at Truist
- OrthoPediatrics Joins Alliance for Pediatric Device Innovation
- Needham biotechnology analysts to hold an analyst/industry conference call